Scalper1 News
Medical-device maker Edwards Lifesciences (EW) was rising in heavy trading Thursday after it received an upgrade based on a bullish outlook for its Sapien 3 transcatheter aortic valve replacement (TAVR). SunTrust Robinson Humphrey analyst Bruce Nudell upgraded Edwards stock to buy from neutral and raised his price target to 88 from 86 based on last Friday’s announcement that the FDA had approved a new study of the Sapien 3 in elderly patients who Scalper1 News
Scalper1 News